Sun Pharma Elevates Kirti Ganorkar to Managing Director Following Shareholder Approval Process:

Sun Pharma Elevates Kirti Ganorkar to Managing Director Following Shareholder Approval Process:

Daily Current Affairs   /   Sun Pharma Elevates Kirti Ganorkar to Managing Director Following Shareholder Approval Process:

Change Language English Hindi

Category : Appointment/Resignation Published on: June 17 2025

Share on facebook

Sun Pharmaceutical Industries Ltd. has announced the appointment of Kirti Ganorkar as its new Managing Director, effective September 1, 2025, following approval from its shareholders at the AGM scheduled for July 31. Dilip Shanghvi, the current MD, will remain actively involved as Executive Director and Board Chair. Ganorkar will serve a five-year term to lead India's largest pharmaceutical company.

Recent Post's

  • New Zealand introduces Parent Boost Visa with a 10-year stay provision for immigrants’ parents.

    Read More....

  • Indian forces conduct high-risk operation to rescue fire-hit Singaporean vessel near Kochi.

    Read More....

  • India launches green skills-based EV training program in partnership with Shell.

    Read More....

  • Sun Pharma appoints Kirti Ganorkar as new Managing Director from September 1, 2025.

    Read More....

  • SBI General Insurance names Mohd. Arif Khan as Deputy CEO to boost leadership strength.

    Read More....

  • Ganesh Baliga appointed as MD and Head of Citi India Solutions to expand tech base.

    Read More....

  • HBL Engineering secures ₹133 crore contract for Kavach railway safety system.

    Read More....

  • Samay Project Services IPO worth ₹14.69 crore opens for public subscription.

    Read More....

  • Amazon signs 17-year nuclear energy deal with Talen for powering AWS data centers.

    Read More....

  • Iran halts partial gas output at South Pars after Israeli airstrike triggers fire.

    Read More....

2025 © and Powered By Graposs Edutech Private Limited

Terms & Condition Privacy Policy Disclaimer